ClinicalTrials.gg
Drug

Daratumumab clinical trials

Also written Darzalex, JNJ-54767414 and HuMax-CD38.

Includes 12 studies of Daratumumab and Hyaluronidase-fihj.

studies test it
219
open now
55
in phase 3
32
first study started
2008
Related medicines add 3 studies

Counted the way a researcher would: Daratumumab with its salts, dosage forms, brands and biosimilars. Looking for a trial to join? Including related medicines shows more you could take part in.

This browser remembers your choice.

How each study uses daratumumab is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the daratumumab studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
16 Nov 2015 · DARZALEX · BLA 761036 (FDA, Drugs@FDA)
European Union
20 May 2016 · Darzalex · EMEA/H/C/004077 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Daratumumab
156
Anti-CD38 Monoclonal Antibody
23
Daratumumab Injection
13
Daratumumab SC
8
Daratumumab-fihj
6

Brand

Darzalex
78

Development codes

JNJ-54767414
43
HuMax-CD38
33

In one entry with another drug

Given together, or one or the other

Daratumumab/rHuPH20
2
Daratumumab / Hyaluronidase Injection
2

Biosimilars

HLX15
1

Studies by the year they started

219 studies that test it; most in 2019 (26)

Studies that test daratumumab, by start year
YearStudies
20081
20131
20144
20158
20168
201723
201825
201926
202017
202126
202220
202319
202416
202517
20268

Who runs them

Industry 46 · Other 173

Janssen Research & Development, LLC (24) · Mayo Clinic (11) · M.D. Anderson Cancer Center (9) · Institute of Hematology & Blood Diseases Hospital, China (9) · Hellenic Society of Hematology (6) · Memorial Sloan Kettering Cancer Center (5) · City of Hope Medical Center (5) · Stichting European Myeloma Network (5)

Often tested with

Tested in the same studies.

Dexamethasone (70) · Lenalidomide (36) · Bortezomib (25) · Carfilzomib (18) · Pomalidomide (17) · Ixazomib (11) · Cyclophosphamide (9) · Melphalan (6)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Tested against it · 23 phase 3 studies under way

Daratumumab is the comparator. A study of two new drugs counts under both.

  • 5Belantamab mafodotin · GlaxoSmithKline, PrECOG, LLC. · next primary completion Apr 2031
  • 2Linvoseltamab · Regeneron Pharmaceuticals · next primary completion Jul 2033
  • 2Etentamig · AbbVie · next primary completion Feb 2033
  • 1Equecabtagene autoleucel · Nanjing IASO Biotechnology Co., Ltd. · next primary completion Aug 2027
  • 1Anitocabtagene autoleucel · Kite, A Gilead Company · next primary completion Jul 2028
  • 1QLS4131 · Qilu Pharmaceutical Co., Ltd. · next primary completion Dec 2029
  • 1CM336 · Keymed Biosciences Co.Ltd · next primary completion May 2030
  • 1Lumrotatug · Keymed Biosciences Co.Ltd · next primary completion May 2030
Reaching primary completion within a year · 30, 2 in phase 3

Studies that test daratumumab, phase 3 first.

Studies

Open first, then newest update. How each study uses daratumumab is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 219

See all 219 studies that test daratumumab →

Given beside what is tested · 99 — daratumumab is usual care or a partner of the new treatment

Showing 20 of 99.

As the comparator · 32 — what is tested is compared with daratumumab

Showing 20 of 32.

Codes

What other systems call daratumumab · ClinicalTrials.gg INT005784

  • MeSH (NLM) C556306daratumumabConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) 4Z63YK6E0EDARATUMUMABConfirmed FDA, NLM, Wikidata
  • RxNorm 1721947Confirmed FDA, Wikidata
  • Wikidata Q5222113daratumumabConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C74007DaratumumabOne source FDA
  • DrugBank DB09331One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.